French drug developer NiCox S.A. last week announced plans to buy Aciex Therapeutics
Significant step forward in Nicox's strategy of creating an international ophthalmic company built around therapeutics and diagnostics
Highlights from the posters and papers presented at the 2014 ARVO meeting in Orlando.
Antibiotic innovation has slowed, allowing drug resistance to catch up, but there is still hope for the future of anti-infectives.